MUC1, a highly glycosylated transmembrane glycoprotein, is overexpressed and aberrantly glycosylated by breast cancer cells resulting in changes in the antigenic profile of the tumour-associated glycoforms. This evidence concerns the gene MUC1 and breast cancer.